Levels of the Ifnb1, Cxcl9, Cxcl10 and TNF-α mRNAs in glioma tissues from different treatment groups were determined using qRT-PCR to evaluate the activation of STING signaling. The gene discussed is CXCL9; the disease is central nervous system cancer.